SetPoint Medical previously announced the primary efficacy endpoint of ACR20 response was met in the RESET-RA study, which enrolled 242 participants. An ACR20 response is a composite measure of the ...

Elephant named ‘Kamala’ dies at zoo days before the election – sparking ‘bad omen’ comments online - News of the elephant’s ...

Rheumatoid arthritis (RA) causes your body to mistakenly attack healthy joints and leads to widespread inflammation. RA is a chronic inflammatory autoimmune disease. It causes the body to attack ...

Roughly 82 percent of participants were women. To measure pain, researchers used the Western Ontario and McMaster Universities Arthritis Index (WOMAC). The WOMAC involves participants scoring pain ...

Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of glucagon-like peptide-1 receptor agonists on outcomes in knee osteoarthritis ...

Rheumatoid arthritis (RA) causes a number of painful symptoms, including stiffness, visible swelling, and deformation of the joints in the fingers and hands. Managing inflammation can help reduce ...

Pain relief is the most important goal of treating osteoarthritis (OA). When joints don’t hurt, it’s easier to move, manage everyday activities, and exercise. There are many options for treating OA ...

The partnership will enhance the country’s capacity to explore and develop its offshore resources, bringing with it significant benefits for PNG’s economy and the industry. Mr Maladina signed the ...

If you have rheumatoid arthritis (RA), low-impact exercise can help prevent stiff joints, build muscle, improve endurance, and benefit your heart, bones, and mood. Rheumatoid arthritis is a ...

Osteoarthritis need not be the end of the world — or a stellar tennis career. After years of pain, three-time Grand Slam tennis champion Andy Murray had surgery to 'resurface' his hip joint that ...

Paradigm Biopharmaceuticals’ shares are trading near record lows despite good tidings from the US regulator The company acknowledges that trial delays and funding costs are weighing on some investors ...